Global Angiotensin Receptor Antagonists Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 101622
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Angiotensin Receptor Antagonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Angiotensin Receptor Antagonists market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hypertension accounting for % of the Angiotensin Receptor Antagonists global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Valsartan segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Angiotensin Receptor Antagonists include Pfizer, Novartis, Merck, Astra Zeneca, and Jhonson and Johnson, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Angiotensin Receptor Antagonists market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Valsartan

Telmisartan

Losartan

Irbesartan

Azilsartan

Olmesartan

Market segment by Application can be divided into

Hypertension

Cardiovascular Diseases

Kidney Diseases

Other

The key market players for global Angiotensin Receptor Antagonists market are listed below:

Pfizer

Novartis

Merck

Astra Zeneca

Jhonson and Johnson

Eli Lilly

Sanofi

Bristol-Myers Squibb

Bayer

GSK

Teva Pharmaceutical

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Angiotensin Receptor Antagonists product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Angiotensin Receptor Antagonists, with price, sales, revenue and global market share of Angiotensin Receptor Antagonists from 2019 to 2022.

Chapter 3, the Angiotensin Receptor Antagonists competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Angiotensin Receptor Antagonists breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Angiotensin Receptor Antagonists market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Angiotensin Receptor Antagonists.

Chapter 13, 14, and 15, to describe Angiotensin Receptor Antagonists sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Angiotensin Receptor Antagonists Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Angiotensin Receptor Antagonists Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 Valsartan

1.2.3 Telmisartan

1.2.4 Losartan

1.2.5 Irbesartan

1.2.6 Azilsartan

1.2.7 Olmesartan

1.3 Market Analysis by Application

1.3.1 Overview: Global Angiotensin Receptor Antagonists Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hypertension

1.3.3 Cardiovascular Diseases

1.3.4 Kidney Diseases

1.3.5 Other

1.4 Global Angiotensin Receptor Antagonists Market Size & Forecast

1.4.1 Global Angiotensin Receptor Antagonists Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Angiotensin Receptor Antagonists Sales in Volume (2017-2028)

1.4.3 Global Angiotensin Receptor Antagonists Price (2017-2028)

1.5 Global Angiotensin Receptor Antagonists Production Capacity Analysis

1.5.1 Global Angiotensin Receptor Antagonists Total Production Capacity (2017-2028)

1.5.2 Global Angiotensin Receptor Antagonists Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Angiotensin Receptor Antagonists Market Drivers

1.6.2 Angiotensin Receptor Antagonists Market Restraints

1.6.3 Angiotensin Receptor Antagonists Trends Analysis

2 Manufacturers Profiles

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Pfizer Details

2.1.2 Pfizer Major Business

2.1.3 Pfizer Angiotensin Receptor Antagonists Product and Services

2.1.4 Pfizer Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis Angiotensin Receptor Antagonists Product and Services

2.2.4 Novartis Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3 Merck

2.3.1 Merck Details

2.3.2 Merck Major Business

2.3.3 Merck Angiotensin Receptor Antagonists Product and Services

2.3.4 Merck Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4 Astra Zeneca

2.4.1 Astra Zeneca Details

2.4.2 Astra Zeneca Major Business

2.4.3 Astra Zeneca Angiotensin Receptor Antagonists Product and Services

2.4.4 Astra Zeneca Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5 Jhonson and Johnson

2.5.1 Jhonson and Johnson Details

2.5.2 Jhonson and Johnson Major Business

2.5.3 Jhonson and Johnson Angiotensin Receptor Antagonists Product and Services

2.5.4 Jhonson and Johnson Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6 Eli Lilly

2.6.1 Eli Lilly Details

2.6.2 Eli Lilly Major Business

2.6.3 Eli Lilly Angiotensin Receptor Antagonists Product and Services

2.6.4 Eli Lilly Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7 Sanofi

2.7.1 Sanofi Details

2.7.2 Sanofi Major Business

2.7.3 Sanofi Angiotensin Receptor Antagonists Product and Services

2.7.4 Sanofi Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8 Bristol-Myers Squibb

2.8.1 Bristol-Myers Squibb Details

2.8.2 Bristol-Myers Squibb Major Business

2.8.3 Bristol-Myers Squibb Angiotensin Receptor Antagonists Product and Services

2.8.4 Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9 Bayer

2.9.1 Bayer Details

2.9.2 Bayer Major Business

2.9.3 Bayer Angiotensin Receptor Antagonists Product and Services

2.9.4 Bayer Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10 GSK

2.10.1 GSK Details

2.10.2 GSK Major Business

2.10.3 GSK Angiotensin Receptor Antagonists Product and Services

2.10.4 GSK Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11 Teva Pharmaceutical

2.11.1 Teva Pharmaceutical Details

2.11.2 Teva Pharmaceutical Major Business

2.11.3 Teva Pharmaceutical Angiotensin Receptor Antagonists Product and Services

2.11.4 Teva Pharmaceutical Angiotensin Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Angiotensin Receptor Antagonists Breakdown Data by Manufacturer

3 Angiotensin Receptor Antagonists Breakdown Data by Manufacturer

3.1 Global Angiotensin Receptor Antagonists Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Angiotensin Receptor Antagonists Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Angiotensin Receptor Antagonists

3.4 Market Concentration Rate

3.4.1 Top 3 Angiotensin Receptor Antagonists Manufacturer Market Share in 2021

3.4.2 Top 6 Angiotensin Receptor Antagonists Manufacturer Market Share in 2021

3.5 Global Angiotensin Receptor Antagonists Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Angiotensin Receptor Antagonists Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4 Market Analysis by Region

4.1 Global Angiotensin Receptor Antagonists Market Size by Region

4.1.1 Global Angiotensin Receptor Antagonists Sales in Volume by Region (2017-2028)

4.1.2 Global Angiotensin Receptor Antagonists Revenue by Region (2017-2028)

4.2 North America Angiotensin Receptor Antagonists Revenue (2017-2028)

4.3 Europe Angiotensin Receptor Antagonists Revenue (2017-2028)

4.4 Asia-Pacific Angiotensin Receptor Antagonists Revenue (2017-2028)

4.5 South America Angiotensin Receptor Antagonists Revenue (2017-2028)

4.6 Middle East and Africa Angiotensin Receptor Antagonists Revenue (2017-2028)

5 Market Segment by Type

5 Market Segment by Type

5.1 Global Angiotensin Receptor Antagonists Sales in Volume by Type (2017-2028)

5.2 Global Angiotensin Receptor Antagonists Revenue by Type (2017-2028)

5.3 Global Angiotensin Receptor Antagonists Price by Type (2017-2028)

6 Market Segment by Application

6 Market Segment by Application

6.1 Global Angiotensin Receptor Antagonists Sales in Volume by Application (2017-2028)

6.2 Global Angiotensin Receptor Antagonists Revenue by Application (2017-2028)

6.3 Global Angiotensin Receptor Antagonists Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7 North America by Country, by Type, and by Application

7.1 North America Angiotensin Receptor Antagonists Sales by Type (2017-2028)

7.2 North America Angiotensin Receptor Antagonists Sales by Application (2017-2028)

7.3 North America Angiotensin Receptor Antagonists Market Size by Country

7.3.1 North America Angiotensin Receptor Antagonists Sales in Volume by Country (2017-2028)

7.3.2 North America Angiotensin Receptor Antagonists Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8 Europe by Country, by Type, and by Application

8.1 Europe Angiotensin Receptor Antagonists Sales by Type (2017-2028)

8.2 Europe Angiotensin Receptor Antagonists Sales by Application (2017-2028)

8.3 Europe Angiotensin Receptor Antagonists Market Size by Country

8.3.1 Europe Angiotensin Receptor Antagonists Sales in Volume by Country (2017-2028)

8.3.2 Europe Angiotensin Receptor Antagonists Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Angiotensin Receptor Antagonists Sales by Type (2017-2028)

9.2 Asia-Pacific Angiotensin Receptor Antagonists Sales by Application (2017-2028)

9.3 Asia-Pacific Angiotensin Receptor Antagonists Market Size by Region

9.3.1 Asia-Pacific Angiotensin Receptor Antagonists Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Angiotensin Receptor Antagonists Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10 South America by Region, by Type, and by Application

10.1 South America Angiotensin Receptor Antagonists Sales by Type (2017-2028)

10.2 South America Angiotensin Receptor Antagonists Sales by Application (2017-2028)

10.3 South America Angiotensin Receptor Antagonists Market Size by Country

10.3.1 South America Angiotensin Receptor Antagonists Sales in Volume by Country (2017-2028)

10.3.2 South America Angiotensin Receptor Antagonists Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Angiotensin Receptor Antagonists Sales by Type (2017-2028)

11.2 Middle East & Africa Angiotensin Receptor Antagonists Sales by Application (2017-2028)

11.3 Middle East & Africa Angiotensin Receptor Antagonists Market Size by Country

11.3.1 Middle East & Africa Angiotensin Receptor Antagonists Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Angiotensin Receptor Antagonists Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12 Raw Material and Industry Chain

12.1 Raw Material of Angiotensin Receptor Antagonists and Key Manufacturers

12.2 Manufacturing Costs Percentage of Angiotensin Receptor Antagonists

12.3 Angiotensin Receptor Antagonists Production Process

12.4 Angiotensin Receptor Antagonists Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Angiotensin Receptor Antagonists Typical Distributors

13.3 Angiotensin Receptor Antagonists Typical Customers

14 Research Findings and Conclusion

14 Research Findings and Conclusion

15 Appendix

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Angiotensin Receptor Antagonists Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Angiotensin Receptor Antagonists Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. Pfizer Basic Information, Manufacturing Base and Competitors

Table 4. Pfizer Major Business

Table 5. Pfizer Angiotensin Receptor Antagonists Product and Services

Table 6. Pfizer Angiotensin Receptor Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. Novartis Basic Information, Manufacturing Base and Competitors

Table 8. Novartis Major Business

Table 9. Novartis Angiotensin Receptor Antagonists Product and Services

Table 10. Novartis Angiotensin Receptor Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. Merck Basic Information, Manufacturing Base and Competitors

Table 12. Merck Major Business

Table 13. Merck Angiotensin Receptor Antagonists Product and Services

Table 14. Merck Angiotensin Receptor Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 15. Astra Zeneca Basic Information, Manufacturing Base and Competitors

Table 16. Astra Zeneca Major Business

Table 17. Astra Zeneca Angiotensin Receptor Antagonists Product and Services

Table 18. Astra Zeneca Angiotensin Receptor Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 19. Jhonson and Johnson Basic Information, Manufacturing Base and Competitors

Table 20. Jhonson and Johnson Major Business

Table 21. Jhonson and Johnson Angiotensin Receptor Antagonists Product and Services

Table 22. Jhonson and Johnson Angiotensin Receptor Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 23. Eli Lilly Basic Information, Manufacturing Base and Competitors

Table 24. Eli Lilly Major Business

Table 25. Eli Lilly Angiotensin Receptor Antagonists Product and Services

Table 26. Eli Lilly Angiotensin Receptor Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 27. Sanofi Basic Information, Manufacturing Base and Competitors

Table 28. Sanofi Major Business

Table 29. Sanofi Angiotensin Receptor Antagonists Product and Services

Table 30. Sanofi Angiotensin Receptor Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 31. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors

Table 32. Bristol-Myers Squibb Major Business

Table 33. Bristol-Myers Squibb Angiotensin Receptor Antagonists Product and Services

Table 34. Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 35. Bayer Basic Information, Manufacturing Base and Competitors

Table 36. Bayer Major Business

Table 37. Bayer Angiotensin Receptor Antagonists Product and Services

Table 38. Bayer Angiotensin Receptor Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 39. GSK Basic Information, Manufacturing Base and Competitors

Table 40. GSK Major Business

Table 41. GSK Angiotensin Receptor Antagonists Product and Services

Table 42. GSK Angiotensin Receptor Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 43. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 44. Teva Pharmaceutical Major Business

Table 45. Teva Pharmaceutical Angiotensin Receptor Antagonists Product and Services

Table 46. Teva Pharmaceutical Angiotensin Receptor Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 47. Global Angiotensin Receptor Antagonists Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)

Table 48. Global Angiotensin Receptor Antagonists Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 49. Market Position of Manufacturers in Angiotensin Receptor Antagonists, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 50. Global Angiotensin Receptor Antagonists Production Capacity by Company, (K Units): 2020 VS 2021

Table 51. Head Office and Angiotensin Receptor Antagonists Production Site of Key Manufacturer

Table 52. Angiotensin Receptor Antagonists New Entrant and Capacity Expansion Plans

Table 53. Angiotensin Receptor Antagonists Mergers & Acquisitions in the Past Five Years

Table 54. Global Angiotensin Receptor Antagonists Sales by Region (2017-2022) & (K Units)

Table 55. Global Angiotensin Receptor Antagonists Sales by Region (2023-2028) & (K Units)

Table 56. Global Angiotensin Receptor Antagonists Revenue by Region (2017-2022) & (USD Million)

Table 57. Global Angiotensin Receptor Antagonists Revenue by Region (2023-2028) & (USD Million)

Table 58. Global Angiotensin Receptor Antagonists Sales by Type (2017-2022) & (K Units)

Table 59. Global Angiotensin Receptor Antagonists Sales by Type (2023-2028) & (K Units)

Table 60. Global Angiotensin Receptor Antagonists Revenue by Type (2017-2022) & (USD Million)

Table 61. Global Angiotensin Receptor Antagonists Revenue by Type (2023-2028) & (USD Million)

Table 62. Global Angiotensin Receptor Antagonists Price by Type (2017-2022) & (USD/Unit)

Table 63. Global Angiotensin Receptor Antagonists Price by Type (2023-2028) & (USD/Unit)

Table 64. Global Angiotensin Receptor Antagonists Sales by Application (2017-2022) & (K Units)

Table 65. Global Angiotensin Receptor Antagonists Sales by Application (2023-2028) & (K Units)

Table 66. Global Angiotensin Receptor Antagonists Revenue by Application (2017-2022) & (USD Million)

Table 67. Global Angiotensin Receptor Antagonists Revenue by Application (2023-2028) & (USD Million)

Table 68. Global Angiotensin Receptor Antagonists Price by Application (2017-2022) & (USD/Unit)

Table 69. Global Angiotensin Receptor Antagonists Price by Application (2023-2028) & (USD/Unit)

Table 70. North America Angiotensin Receptor Antagonists Sales by Country (2017-2022) & (K Units)

Table 71. North America Angiotensin Receptor Antagonists Sales by Country (2023-2028) & (K Units)

Table 72. North America Angiotensin Receptor Antagonists Revenue by Country (2017-2022) & (USD Million)

Table 73. North America Angiotensin Receptor Antagonists Revenue by Country (2023-2028) & (USD Million)

Table 74. North America Angiotensin Receptor Antagonists Sales by Type (2017-2022) & (K Units)

Table 75. North America Angiotensin Receptor Antagonists Sales by Type (2023-2028) & (K Units)

Table 76. North America Angiotensin Receptor Antagonists Sales by Application (2017-2022) & (K Units)

Table 77. North America Angiotensin Receptor Antagonists Sales by Application (2023-2028) & (K Units)

Table 78. Europe Angiotensin Receptor Antagonists Sales by Country (2017-2022) & (K Units)

Table 79. Europe Angiotensin Receptor Antagonists Sales by Country (2023-2028) & (K Units)

Table 80. Europe Angiotensin Receptor Antagonists Revenue by Country (2017-2022) & (USD Million)

Table 81. Europe Angiotensin Receptor Antagonists Revenue by Country (2023-2028) & (USD Million)

Table 82. Europe Angiotensin Receptor Antagonists Sales by Type (2017-2022) & (K Units)

Table 83. Europe Angiotensin Receptor Antagonists Sales by Type (2023-2028) & (K Units)

Table 84. Europe Angiotensin Receptor Antagonists Sales by Application (2017-2022) & (K Units)

Table 85. Europe Angiotensin Receptor Antagonists Sales by Application (2023-2028) & (K Units)

Table 86. Asia-Pacific Angiotensin Receptor Antagonists Sales by Region (2017-2022) & (K Units)

Table 87. Asia-Pacific Angiotensin Receptor Antagonists Sales by Region (2023-2028) & (K Units)

Table 88. Asia-Pacific Angiotensin Receptor Antagonists Revenue by Region (2017-2022) & (USD Million)

Table 89. Asia-Pacific Angiotensin Receptor Antagonists Revenue by Region (2023-2028) & (USD Million)

Table 90. Asia-Pacific Angiotensin Receptor Antagonists Sales by Type (2017-2022) & (K Units)

Table 91. Asia-Pacific Angiotensin Receptor Antagonists Sales by Type (2023-2028) & (K Units)

Table 92. Asia-Pacific Angiotensin Receptor Antagonists Sales by Application (2017-2022) & (K Units)

Table 93. Asia-Pacific Angiotensin Receptor Antagonists Sales by Application (2023-2028) & (K Units)

Table 94. South America Angiotensin Receptor Antagonists Sales by Country (2017-2022) & (K Units)

Table 95. South America Angiotensin Receptor Antagonists Sales by Country (2023-2028) & (K Units)

Table 96. South America Angiotensin Receptor Antagonists Revenue by Country (2017-2022) & (USD Million)

Table 97. South America Angiotensin Receptor Antagonists Revenue by Country (2023-2028) & (USD Million)

Table 98. South America Angiotensin Receptor Antagonists Sales by Type (2017-2022) & (K Units)

Table 99. South America Angiotensin Receptor Antagonists Sales by Type (2023-2028) & (K Units)

Table 100. South America Angiotensin Receptor Antagonists Sales by Application (2017-2022) & (K Units)

Table 101. South America Angiotensin Receptor Antagonists Sales by Application (2023-2028) & (K Units)

Table 102. Middle East & Africa Angiotensin Receptor Antagonists Sales by Region (2017-2022) & (K Units)

Table 103. Middle East & Africa Angiotensin Receptor Antagonists Sales by Region (2023-2028) & (K Units)

Table 104. Middle East & Africa Angiotensin Receptor Antagonists Revenue by Region (2017-2022) & (USD Million)

Table 105. Middle East & Africa Angiotensin Receptor Antagonists Revenue by Region (2023-2028) & (USD Million)

Table 106. Middle East & Africa Angiotensin Receptor Antagonists Sales by Type (2017-2022) & (K Units)

Table 107. Middle East & Africa Angiotensin Receptor Antagonists Sales by Type (2023-2028) & (K Units)

Table 108. Middle East & Africa Angiotensin Receptor Antagonists Sales by Application (2017-2022) & (K Units)

Table 109. Middle East & Africa Angiotensin Receptor Antagonists Sales by Application (2023-2028) & (K Units)

Table 110. Angiotensin Receptor Antagonists Raw Material

Table 111. Key Manufacturers of Angiotensin Receptor Antagonists Raw Materials

Table 112. Direct Channel Pros & Cons

Table 113. Indirect Channel Pros & Cons

Table 114. Angiotensin Receptor Antagonists Typical Distributors

Table 115. Angiotensin Receptor Antagonists Typical Customers

List of Figures

Figure 1. Angiotensin Receptor Antagonists Picture

Figure 2. Global Angiotensin Receptor Antagonists Revenue Market Share by Type in 2021

Figure 3. Valsartan

Figure 4. Telmisartan

Figure 5. Losartan

Figure 6. Irbesartan

Figure 7. Azilsartan

Figure 8. Olmesartan

Figure 9. Global Angiotensin Receptor Antagonists Revenue Market Share by Application in 2021

Figure 10. Hypertension

Figure 11. Cardiovascular Diseases

Figure 12. Kidney Diseases

Figure 13. Other

Figure 14. Global Angiotensin Receptor Antagonists Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028

Figure 15. Global Angiotensin Receptor Antagonists Revenue and Forecast (2017-2028) & (USD Million)

Figure 16. Global Angiotensin Receptor Antagonists Sales (2017-2028) & (K Units)

Figure 17. Global Angiotensin Receptor Antagonists Price (2017-2028) & (USD/Unit)

Figure 18. Global Angiotensin Receptor Antagonists Production Capacity (2017-2028) & (K Units)

Figure 19. Global Angiotensin Receptor Antagonists Production Capacity by Geographic Region: 2022 VS 2028

Figure 20. Angiotensin Receptor Antagonists Market Drivers

Figure 21. Angiotensin Receptor Antagonists Market Restraints

Figure 22. Angiotensin Receptor Antagonists Market Trends

Figure 23. Global Angiotensin Receptor Antagonists Sales Market Share by Manufacturer in 2021

Figure 24. Global Angiotensin Receptor Antagonists Revenue Market Share by Manufacturer in 2021

Figure 25. Angiotensin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 26. Top 3 Angiotensin Receptor Antagonists Manufacturer (Revenue) Market Share in 2021

Figure 27. Top 6 Angiotensin Receptor Antagonists Manufacturer (Revenue) Market Share in 2021

Figure 28. Global Angiotensin Receptor Antagonists Sales Market Share by Region (2017-2028)

Figure 29. Global Angiotensin Receptor Antagonists Revenue Market Share by Region (2017-2028)

Figure 30. North America Angiotensin Receptor Antagonists Revenue (2017-2028) & (USD Million)

Figure 31. Europe Angiotensin Receptor Antagonists Revenue (2017-2028) & (USD Million)

Figure 32. Asia-Pacific Angiotensin Receptor Antagonists Revenue (2017-2028) & (USD Million)

Figure 33. South America Angiotensin Receptor Antagonists Revenue (2017-2028) & (USD Million)

Figure 34. Middle East & Africa Angiotensin Receptor Antagonists Revenue (2017-2028) & (USD Million)

Figure 35. Global Angiotensin Receptor Antagonists Sales Market Share by Type (2017-2028)

Figure 36. Global Angiotensin Receptor Antagonists Revenue Market Share by Type (2017-2028)

Figure 37. Global Angiotensin Receptor Antagonists Price by Type (2017-2028) & (USD/Unit)

Figure 38. Global Angiotensin Receptor Antagonists Sales Market Share by Application (2017-2028)

Figure 39. Global Angiotensin Receptor Antagonists Revenue Market Share by Application (2017-2028)

Figure 40. Global Angiotensin Receptor Antagonists Price by Application (2017-2028) & (USD/Unit)

Figure 41. North America Angiotensin Receptor Antagonists Sales Market Share by Type (2017-2028)

Figure 42. North America Angiotensin Receptor Antagonists Sales Market Share by Application (2017-2028)

Figure 43. North America Angiotensin Receptor Antagonists Sales Market Share by Country (2017-2028)

Figure 44. North America Angiotensin Receptor Antagonists Revenue Market Share by Country (2017-2028)

Figure 45. United States Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Canada Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Mexico Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Europe Angiotensin Receptor Antagonists Sales Market Share by Type (2017-2028)

Figure 49. Europe Angiotensin Receptor Antagonists Sales Market Share by Application (2017-2028)

Figure 50. Europe Angiotensin Receptor Antagonists Sales Market Share by Country (2017-2028)

Figure 51. Europe Angiotensin Receptor Antagonists Revenue Market Share by Country (2017-2028)

Figure 52. Germany Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. France Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. United Kingdom Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Russia Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Italy Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Asia-Pacific Angiotensin Receptor Antagonists Sales Market Share by Region (2017-2028)

Figure 58. Asia-Pacific Angiotensin Receptor Antagonists Sales Market Share by Application (2017-2028)

Figure 59. Asia-Pacific Angiotensin Receptor Antagonists Sales Market Share by Region (2017-2028)

Figure 60. Asia-Pacific Angiotensin Receptor Antagonists Revenue Market Share by Region (2017-2028)

Figure 61. China Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Japan Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Korea Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. India Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Southeast Asia Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Australia Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. South America Angiotensin Receptor Antagonists Sales Market Share by Type (2017-2028)

Figure 68. South America Angiotensin Receptor Antagonists Sales Market Share by Application (2017-2028)

Figure 69. South America Angiotensin Receptor Antagonists Sales Market Share by Country (2017-2028)

Figure 70. South America Angiotensin Receptor Antagonists Revenue Market Share by Country (2017-2028)

Figure 71. Brazil Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Argentina Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Middle East & Africa Angiotensin Receptor Antagonists Sales Market Share by Type (2017-2028)

Figure 74. Middle East & Africa Angiotensin Receptor Antagonists Sales Market Share by Application (2017-2028)

Figure 75. Middle East & Africa Angiotensin Receptor Antagonists Sales Market Share by Region (2017-2028)

Figure 76. Middle East & Africa Angiotensin Receptor Antagonists Revenue Market Share by Region (2017-2028)

Figure 77. Turkey Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Egypt Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Saudi Arabia Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. South Africa Angiotensin Receptor Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Manufacturing Cost Structure Analysis of Angiotensin Receptor Antagonists in 2021

Figure 82. Manufacturing Process Analysis of Angiotensin Receptor Antagonists

Figure 83. Angiotensin Receptor Antagonists Industrial Chain

Figure 84. Sales Channel: Direct Channel vs Indirect Channel

Figure 85. Methodology

Figure 86. Research Process and Data Source